Tevogen Bio Holdings Inc. (TVGN)
NASDAQ: TVGN · Real-Time Price · USD
0.4006
-0.0211 (-5.00%)
At close: Dec 5, 2025, 4:00 PM EST
0.4100
+0.0094 (2.35%)
After-hours: Dec 5, 2025, 7:00 PM EST
Tevogen Bio Holdings Employees
Tevogen Bio Holdings had 18 employees as of December 31, 2024.
Employees
18
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,745,383
Market Cap
79.60M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 18 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TVGN News
- 22 days ago - Tevogen Highlights Continued Capital Efficiency Following Filing of Q3 2025 Form 10-Q - GlobeNewsWire
- 4 weeks ago - Tevogen Reports Major Clinical Milestone: Expands HLA Coverage of its Investigational Precision T Cell Therapy for Acute and Long COVID - GlobeNewsWire
- 4 weeks ago - Tevogen Clarifies Reported Financials, Highlighting Strong Capital Efficiency and Low Cash Burn - GlobeNewsWire
- 5 weeks ago - Tevogen Senior Management Engages with Business and Community Leaders and Highlights Recent Progress - GlobeNewsWire
- 7 weeks ago - Tevogen Updates on TVGN 489 Following Growing Long COVID Patient Interest - GlobeNewsWire
- 2 months ago - Tevogen Marks Major Milestone in Its AI Initiative to Enhance Efficacy of T Cell–Based Therapies with 100x PredicTcell™ Beta Data Expansion - GlobeNewsWire
- 2 months ago - Tevogen Highlights Potential Role of TVGN 489 in Eliminating Persistent Viral Reservoirs Linked to Long COVID - GlobeNewsWire
- 2 months ago - Tevogen Commends HHS for Addressing Long COVID, Emphasizes TVGN 489's Potential Impact for 20 Million Americans - GlobeNewsWire